PathoGene: Funding, Investors & Team (Oct 2026)
PathoGene, Inc. is a private, seed-stage precision MedTech startup headquartered in Los Angeles, with R&D operations located in Monrovia, California. We are developing a sample-to-answer in vitro diagnostic medical device that detects and identifies all known microscopic human pathogens along with their antimicrobial resistance profiles on a single 6-hour test panel. To do this, we leverage robotic automation, third-generation DNA and RNA sequencing, and cloud computing technologies to report a molecular diagnosis to care providers and disease surveillance systems in real-time. Our goal is to deliver the necessary diagnostic tools for doctors and medical staff to make optimal treatment decisions that can ultimately improve public health as a whole, and we believe that our sample-to-answer technology can become the global standard of care for diagnosing infectious diseases.
PathoGene has raised $500k across 1 funding round on record, the most recent a Seed of $500k announced in Jul 2021.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
PathoGene Company Profile and Key Stats
Latest funding round on record: Jul 2021.
PathoGene Funding Rounds
PathoGene Founders and Leadership Team
No contact details are on record for this team yet.
PathoGene Funding Compared to Other Biotechnology Startups
PathoGene's latest round of $500k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like PathoGene in Biotechnology and Los Angeles
Companies Similar to PathoGene
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
PathoGene Funding FAQs
What does PathoGene do?
PathoGene, Inc. is a private, seed-stage precision MedTech startup headquartered in Los Angeles, with R&D operations located in Monrovia, California. We are developing a sample-to-answer in vitro diagnostic medical device that detects and identifies all known microscopic human pathogens along with their antimicrobial resistance profiles on a single 6-hour test panel. To do this, we leverage robotic automation, third-generation DNA and RNA sequencing, and cloud computing technologies to report a molecular diagnosis to care providers and disease surveillance systems in real-time. Our goal is to deliver the necessary diagnostic tools for doctors and medical staff to make optimal treatment decisions that can ultimately improve public health as a whole, and we believe that our sample-to-answer technology can become the global standard of care for diagnosing infectious diseases.
How much funding has PathoGene raised?
PathoGene has raised $500k across 1 round on record. The most recent is a Seed of $500k announced in Jul 2021.
When did PathoGene last raise funding?
PathoGene's most recent funding round on record is a Seed of $500k, announced in Jul 2021.
Who is the CEO of PathoGene?
Joseph Mickel is listed as CEO at PathoGene.
Where is PathoGene headquartered?
PathoGene is based in Los Angeles, California, United States.
How many employees does PathoGene have?
PathoGene is in the 1-10 employee band.
How does PathoGene's funding compare to other Biotechnology startups?
PathoGene's latest round of $500k is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's PathoGene Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for PathoGene is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.